<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(12)</volume><submitter>Gupta S</submitter><pubmed_abstract>&lt;h4>Rationale &amp; objective&lt;/h4>Pregnant women with prepregnancy chronic kidney disease (CKD) are underdiagnosed and experience adverse outcomes. Limited research exists on peripregnancy health care utilization by women with evidence of CKD.&lt;h4>Study design&lt;/h4>Retrospective cohort analysis.&lt;h4>Setting &amp; participants&lt;/h4>Women with laboratory signs of prepregnancy CKD who had a pregnancy event between January 1, 2016, and March 1, 2023, at Montefiore Health System in Bronx, NY, were included.&lt;h4>Exposure &amp; outcomes&lt;/h4>We investigated rates of CKD diagnosis, adverse maternal and fetal outcomes, and peripregnancy health care utilization among a sample of women with evidence of prepregnancy CKD.&lt;h4>Analytical approach&lt;/h4>We tested the proportion of women with laboratory signs of CKD who had a diagnosis code for CKD entered on their problem list. We also examined the association of different eGFR/proteinuria cutoffs among the cohort with (1) adverse pregnancy outcomes, (2) postpregnancy CKD prevalence, and (3) peripregnancy health utilization.&lt;h4>Results&lt;/h4>Of the 247 pregnant women who met criteria for prepregnancy CKD by estimated glomerular filtration rate (eGFR) or proteinuria, 8.1% had spontaneous abortion, 10.9% had missed abortion, 12.9% had CKD listed in problem list. Out of 80.9% of pregnancy that reached fetal viability, 12.5% had early preterm delivery, 22.6% developed gestational hypertension, and 20.0% of their infants required neonatal intensive care unit admission, with worse outcomes seen in those with severe CKD (defined as eGFR &lt; 45 mL/min/1.73 m&lt;sup>2&lt;/sup> or proteinuria > 1,000 mg/g). Among women with CKD, 27.6% were seen by primary care within 1 year before pregnancy while less than 0.1% were ever seen by a nephrologist. Among women with severe CKD, only 40% were seen by nephrology during pregnancy, and less than 50% had a nephrology appointment arranged at discharge.&lt;h4>Limitations&lt;/h4>Retrospective analysis of a single-center data source.&lt;h4>Conclusions&lt;/h4>Pregnant women with CKD were frequently underdiagnosed and not sufficiently integrated into care before, during, or after pregnancy.</pubmed_abstract><journal>Kidney medicine</journal><pagination>101147</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12677166</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Health Care Utilization Among Pregnant Women With Pre-existing Kidney Disease: A Retrospective Cohort Analysis.</pubmed_title><pmcid>PMC12677166</pmcid><pubmed_authors>Gupta S</pubmed_authors><pubmed_authors>Jim B</pubmed_authors><pubmed_authors>Vasa A</pubmed_authors><pubmed_authors>Cervantes L</pubmed_authors><pubmed_authors>Reidy K</pubmed_authors><pubmed_authors>Golestaneh L</pubmed_authors><pubmed_authors>Vani K</pubmed_authors><pubmed_authors>Rizzolo K</pubmed_authors><pubmed_authors>Isaac J</pubmed_authors><pubmed_authors>Wolfe D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Health Care Utilization Among Pregnant Women With Pre-existing Kidney Disease: A Retrospective Cohort Analysis.</name><description>&lt;h4>Rationale &amp; objective&lt;/h4>Pregnant women with prepregnancy chronic kidney disease (CKD) are underdiagnosed and experience adverse outcomes. Limited research exists on peripregnancy health care utilization by women with evidence of CKD.&lt;h4>Study design&lt;/h4>Retrospective cohort analysis.&lt;h4>Setting &amp; participants&lt;/h4>Women with laboratory signs of prepregnancy CKD who had a pregnancy event between January 1, 2016, and March 1, 2023, at Montefiore Health System in Bronx, NY, were included.&lt;h4>Exposure &amp; outcomes&lt;/h4>We investigated rates of CKD diagnosis, adverse maternal and fetal outcomes, and peripregnancy health care utilization among a sample of women with evidence of prepregnancy CKD.&lt;h4>Analytical approach&lt;/h4>We tested the proportion of women with laboratory signs of CKD who had a diagnosis code for CKD entered on their problem list. We also examined the association of different eGFR/proteinuria cutoffs among the cohort with (1) adverse pregnancy outcomes, (2) postpregnancy CKD prevalence, and (3) peripregnancy health utilization.&lt;h4>Results&lt;/h4>Of the 247 pregnant women who met criteria for prepregnancy CKD by estimated glomerular filtration rate (eGFR) or proteinuria, 8.1% had spontaneous abortion, 10.9% had missed abortion, 12.9% had CKD listed in problem list. Out of 80.9% of pregnancy that reached fetal viability, 12.5% had early preterm delivery, 22.6% developed gestational hypertension, and 20.0% of their infants required neonatal intensive care unit admission, with worse outcomes seen in those with severe CKD (defined as eGFR &lt; 45 mL/min/1.73 m&lt;sup>2&lt;/sup> or proteinuria > 1,000 mg/g). Among women with CKD, 27.6% were seen by primary care within 1 year before pregnancy while less than 0.1% were ever seen by a nephrologist. Among women with severe CKD, only 40% were seen by nephrology during pregnancy, and less than 50% had a nephrology appointment arranged at discharge.&lt;h4>Limitations&lt;/h4>Retrospective analysis of a single-center data source.&lt;h4>Conclusions&lt;/h4>Pregnant women with CKD were frequently underdiagnosed and not sufficiently integrated into care before, during, or after pregnancy.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-05T23:33:00.103Z</modification><creation>2026-05-23T03:13:42.639Z</creation></dates><accession>S-EPMC12677166</accession><cross_references><pubmed>41357763</pubmed><doi>10.1016/j.xkme.2025.101147</doi></cross_references></HashMap>